12月 2025
- 首頁
- Medisca
12月 2025Medisca的市場佔有率分析
Discover our commitment to empowering personalized wellness for all by bridging the gaps in healthcare with quality, technology, and education.
Medisca(包含公司地區)
查看更多網站流量與參與度資訊- medisca.com.au
Medisca截至 12月 2025 的總收入為 50M - 75M
Medisca 熱門網域產生的總收入
Medisca 熱門網域 3 年內的總收入
Medisca 熱門網域的總收入
Medisca的熱門網域總造訪量
了解Medisca市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Medisca的熱門網域平均造訪時長
分析Medisca參與度指標。
過去 3 個月平均造訪時長
子公司細目
Medisca的熱門網域平均頁面瀏覽量
了解Medisca如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Medisca
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Medisca Inc. hired Sanjay D. Goorachurn as chief executive officer on Apr 16th '24.Montreal, QC (April 16, 2024) - Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company's new CEO, as founders, Tony Dos Santos and Maria Zaccardo, transition into strategic advisory roles as Chair and Vice Chair, respectively.
4月 16, 2024閱讀更多
新聞Medisca Inc. partnered with Padagis LLC on Dec 9th '21.On December 9, 2021, Medisca entered into an exclusive global manufacture, supply, license and distribution agreement with Padagis (formerly, the Rx Division of Perrigo) for their ORA Product Line consisting of the following Padagis products in finished form ORA-Plus®, ORA-Sweet®, ORA-Sweet® SF, ORA-Blend®, and ORA-Blend® SF.
1月 11, 2022閱讀更多
查看所有Medisca信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。